1. The Defendant (Counterclaim Plaintiff) paid 840,000 won to the Plaintiff (Counterclaim Defendant) and its related amount from March 7, 2014 to January 26, 2017.

A principal lawsuit and counterclaim shall also be deemed a principal lawsuit and counterclaim.

1. Basic facts

A. On June 15, 2001, the Plaintiff entered into an insurance contract between the Plaintiff and the Defendant on June 15, 2001 as the insured (hereinafter “instant insurance contract”).

Article 17 of the General Terms and Conditions of the State Contracts (Definition and Confirmation of Diagnosis of 11 Primary Diseases) (1) The term “acta 11st Disease Disease Classification” in this Agreement refers to the disease specified in the 11st Disease Classification (See attached Table 6) during the 11th Ethical Disease Classification. [Attachment 6] Article 22 [the definitions and places of hospitalization and surgery are included in the 11st infectious disease during the active period] [the definitions and places of hospitalization and surgery] (1) The term “hospitalize” in this Agreement means a doctor, dentist, or oriental medical doctor (hereinafter referred to as “doctor”).

) In the event that it is recognized as necessary to provide treatment due to cancer, an internal cancer, an activity 11-curology, a urology disease, a urology disease, or a urology disease or an urology disease, it refers to entering a domestic hospital, a member of a foreign medical institution as defined in Article 3 of the Medical Service Act, or a foreign company recognized as equivalent to the above, in order to concentrate on medical treatment under the control of the doctor, due to difficulties in treatment at home, etc.

6. When the insured has been hospitalized for not less than four days for a direct purpose of treating an active 11th class disease or an acute disease during the insurance period, when he/she has been diagnosed and confirmed as a clinical cancer, has been hospitalized for not less than four consecutive days for a direct purpose of treating that th class cancer, or when he/she has been diagnosed and confirmed as cancer after the 90th day including the date of contract, and has continued to be directly aiming at treating that cancer after the 90th day including the date of contract.